Business Context and Reporting Period
This Form 8-K is a current report filed by ReWalk Robotics Ltd. (noting the input metadata reference to "Lifeward Ltd." appears to be an error as the filing explicitly names ReWalk Robotics) on July 28, 2023. The registrant is incorporated in Israel and its ordinary shares trade on the Nasdaq Capital Market under the symbol RWLK. The report addresses corporate governance changes regarding the Board of Directors and shareholder meeting logistics.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes
- Board Departures: Aryeh (Arik) Dan and Wayne B. Weisman, current Class III directors, notified the Board they will not stand for reelection at the 2023 Annual General Meeting.
- Reason for Departure: The departures are part of the Company's policy to routinely refresh the Board composition. The filing explicitly states there was no disagreement with the Company regarding operations, policies, or practices.
- Board Size Reduction: The Board does not expect to nominate replacement candidates. Consequently, the Board size is anticipated to reduce from ten (10) to eight (8) members following the Annual Meeting.
Guidance, Outlook, and Corporate Actions
- Annual Meeting Date: The 2023 Annual General Meeting of Shareholders is scheduled for September 13, 2023.
- Shareholder Proposals: Shareholders wishing to submit proposals for inclusion in proxy materials under Rule 14a-8 must submit them by August 7, 2023.
- Management Commentary: The Company expressed gratitude to the departing directors for their distinguished service and lasting contributions.
Investor Verification Checklist
- Verify the exact composition of the Board of Directors following the September 13, 2023, Annual Meeting.
- Confirm whether any new director nominations are made outside of the standard proxy process prior to the meeting.
- Review the Company's most recent 10-K or 10-Q filings for actual financial performance data, as this 8-K contains none.
- Monitor for any future filings regarding the strategic rationale for reducing the Board size.